Literature DB >> 22689032

[Viral respiratory co-infections in pediatric patients admitted for acute respiratory infection and their impact on clinical severity].

Pamela Martínez1, Jaime Cordero, Cristián Valverde, Nancy Unanue, Roberto Dalmazzo, Paula Piemonte, Ivonne Vergara, Juan P Torres.   

Abstract

INTRODUCTION: Respiratory viruses are the leading cause of acute respiratory tract infection (ARI) in children. It has been reported that viral respiratory co-infection could be associated with severe clinical course.
OBJECTIVES: To describe the frequency of viral co-infection in children admitted for AlRI and evaluate whether this co-infection was associated with more severe clinical course. PATIENTS AND METHODS: Prospective, descriptive study in pediatric patients who were hospitalized for ARI, with molecular detection of at least 1 respiratory virus in nasopharyngeal sample studied by PCR-Microarray for 17 respiratory viruses.
RESULTS: 110 out of 147 patients with detection of > 1 respiratory virus were included. Viral co-infection was detected in 41/110 (37%). 22/110 children (20%) were classified as moderate to severe clinical course and 88/110 (80%) were classified as mild clinical course. In the group of moderate to severe clinical course, viral respiratory co-infection was detected in 6/22 (27.3%), compared to 35/88 (39.8 %) in the mild clinical course group. No statistically significant difference was found regarding the presence of co-infection between groups (p = 0.33).
CONCLUSIONS: We detected high rates of viral co-infection in children with ARI. It was not possible to demonstrate that viral co-infections were related with severe clinical course in hospitalized children.

Entities:  

Mesh:

Year:  2012        PMID: 22689032     DOI: 10.4067/S0716-10182012000200008

Source DB:  PubMed          Journal:  Rev Chilena Infectol        ISSN: 0716-1018            Impact factor:   0.520


  4 in total

1.  Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen.

Authors:  Jérôme O Wishaupt; Tjeerd van der Ploeg; Ronald de Groot; Florens G A Versteegh; Nico G Hartwig
Journal:  BMC Infect Dis       Date:  2017-01-11       Impact factor: 3.090

2.  Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial.

Authors:  M E Santolaya; A M Alvarez; M Acuña; C L Avilés; C Salgado; J Tordecilla; M Varas; M Venegas; M Villarroel; M Zubieta; A Toso; A Bataszew; M J Farfán; V de la Maza; A Vergara; R Valenzuela; J P Torres
Journal:  Clin Microbiol Infect       Date:  2016-11-14       Impact factor: 8.067

Review 3.  Respiratory viral coinfection and disease severity in children: A systematic review and meta-analysis.

Authors:  Marcelo Comerlato Scotta; Valentina Coutinho Baldoto Gava Chakr; Angela de Moura; Rafaela Garces Becker; Ana Paula Duarte de Souza; Marcus Herbert Jones; Leonardo Araújo Pinto; Edgar Enrique Sarria; Paulo Marcio Pitrez; Renato Tetelbom Stein; Rita Mattiello
Journal:  J Clin Virol       Date:  2016-04-30       Impact factor: 3.168

Review 4.  PCR testing for paediatric acute respiratory tract infections.

Authors:  Jérôme O Wishaupt; Florens G A Versteegh; Nico G Hartwig
Journal:  Paediatr Respir Rev       Date:  2014-08-05       Impact factor: 2.726

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.